hMAO-B-IN-7

• UNSPSC Description:

  hMAO-B-IN-7 (compound 11n) is a potent and blood–brain barrier (BBB) penetrable inhibitor of human monoamine oxidase-B (hMAO-B), with the IC50 value of 0.79±0.05 μM. hMAO-B-IN-7 can be used for Alzheimer’s disease (AD) and Parkinson’s disease (PD) research[1].

• Target Antigen:

  Monoamine Oxidase

• Type:

  Reference compound

• Related Pathways:

  Neuronal Signaling

• Applications:

  Neuroscience-Neurodegeneration

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/hmao-b-in-7.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC1=C(C(C=CN1CCN2C(C3=CC=C(C=C3C2=O)OCC4=CC=C(C=C4)F)=O)=O)O

• Molecular Weight:

  422.41

• References & Citations:

  [1]Xi Zhu, et al. Exploration of the novel phthalimide-hydroxypyridinone derivatives as multifunctional drug candidates against Alzheimer’s disease. Bioorg Chem. 2023 Dec:141:106817.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2955577-14-5